EZR and breast carcinoma: Ezrin expression has been found to be positively related to the degree of malignancy in many tumors, and its expression has also been linked to poor survival in several cancers, including carcinomas of the breast [25], endometrium [26] and in melanomas [27] and soft tissue sarcomas [28, 29].